Hacker group says it stole data on medicines from the owner of Ozempic

Ozempic: weight-loss pen used to treat diabetes and obesity
Disclosure
A hacker group claimed this Tuesday (16) that it stole 1.3 terabytes of data from the Danish pharmaceutical company Novo Nordisk, known for its treatments for diabetes and obesity such as Ozempic and Wegovy.
Named FulcrumSec and created in October 2025, the group said it is considering selling part of the data after being unsuccessful in an attempt to charge US$25 million to return the material to the company.
Do you have any suggestions for a story? Send it to g1
Hackers attacked Novo Nordisk's systems in March and remained infiltrated in the company's networks for two months until they obtained a list of more than 700,000 files, according to what they reported to the cybersecurity website DataBreaches.Net.
Novo Nordisk had already announced last Thursday (11) that it had suffered a cybersecurity incident. According to the company, the attack involved unauthorized access to a limited number of internal systems and personal data from some clinical trial patients.
Now on g1
FulcrumSec said the intrusion allowed access to data from 11,500 clinical trial patients and thousands of employees, as well as details about processing facilities and artificial intelligence models used by the company.
The group also stated that it had access to data such as Novo Nordisk's source code, data on released and unreleased medicines. releases, clinical trial documents, among others.
FulcrumSec said it does not intend to share data on Novo Nordisk employees and patients or on the operation of systems used in the company's facilities.
Novo Nordisk told Reuters that it "is aware of allegations that data allegedly copied externally without authorization from our systems has been published online." company.

Source: G1